H.R.H. Prince Jalawi bin Abdulaziz bin Musaed, Governor of the Najran Region, received the CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, at his office today.
The Saudi Food and Drug Authority (SFDA) organized an interactive workshop at its headquarters in Riyadh to review artificial intelligence (AI) tools and digital solutions designed to support the national food safety system. The workshop highlighted modern technologies implemented in food factories and their impact on compliance with quality and safety standards. This initiative is part of the SFDA’s ongoing commitment to strengthening product safety under its supervision.
The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, met today with business owners and factory representatives from the Najran region at the Chamber of Commerce and Industry in Najran, in the presence of the First Vice Chairman of the Chamber, Mr. Salem bin Mohammed Al Khamsan.
The Saudi Food and Drug Authority (SFDA) participated in the 6th Health Innovation Hackathon, held at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) from February 6–9. The event saw participation from several leading government and private entities dedicated to advancing innovation within the healthcare sector.
As a strategic partner of KSAU-HS, the SFDA provided specialized technical guidance. Its experts in digital transformation and artificial intelligence mentored participants as they developed novel solutions for the healthcare industry.
H.R.H. Prince Faisal bin Nawaf bin Abdulaziz, Governor of Al Jouf Province, met today with H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), at his office.
The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, met on Wednesday at the Al Jouf Chamber of Commerce with various company leaders and representatives from the food, drug, and medical device sectors. The meeting was attended by the Chairman of the Al Jouf Chamber, Dr. Hamdan bin Abdullah Al-Semreen.
The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, met with executives and representatives from the food, drug, and medical device sectors, as well as citizens benefiting from the Authority's services, at the SFDA’s branch headquarters in the Eastern Province.
During these meetings, participants discussed the ongoing development of the food, drug, and medical device regulatory systems. They reviewed current challenges and explored future opportunities aimed at strengthening regulatory compliance and supporting investment in these vital sectors.
The Saudi Food and Drug Authority (SFDA) studied the ability of sending some of its staff to Universities in the Netherlands in a step aiming at diversification and broadening chances of selection for candidates and utilizing Netherlander experiences in the field of food safety via specific short courses.<br />Dr.
H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), affirmed that artificial intelligence (AI) contributes to accelerating the delivery of medicines to patients by supporting drug development and discovery. By simulating clinical trials, AI enables medicines to enter the market in a shorter time and at a lower cost, shortening a process that traditionally takes several years.
The Saudi Food and Drug Authority (SFDA) has signed a Memorandum of Cooperation (MoC) with the Food Industries Polytechnic (FIP) to strengthen collaboration in the training and qualification of national cadres, focusing on building specialized human capital in fields shared by both organizations.
